Top Markets
#1 MowCat MowCat +48.97%
#2 Fake World Assets Fake World Assets +31.61%
#3 aPriori aPriori +28.99%
#4 Bitway Bitway +27.72%
#5 Velvet Velvet +24.90%
#6 OVERTAKE OVERTAKE +19.25%
#7 Verus Coin Verus Coin +16.09%
#8 Derive Derive +15.16%
#9 Zerebro Zerebro +14.96%
#10 Biconomy Biconomy +14.90%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Rangering i aksjer #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Aksjekurs
$0.04895618
Sist synkronisert: 2025-03-18
Markedsverdi
$5.55M
Endring (1 dag)
-0.04%
Endring (1 år)
0.00%
Land
CA
Handel WPD Pharmaceuticals Inc. (WBIO)

Kategori

Healthcare
P/S-forhold for WPD Pharmaceuticals Inc. (WBIO)
P/S-forhold per 2026 TTM: 0
Ifølge WPD Pharmaceuticals Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for WPD Pharmaceuticals Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE